The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPH.L Share News (MPH)

  • There is currently no data for MPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: Kainos Exec Sells GBP4 Million In Shares

Wed, 05th Aug 2020 15:57

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News:

----------

Kainos Group PLC - Belfast-based digital services and platforms for government and commercial customers - Paul Gannon, senior vice president of business development, sells 400,000 shares at average GBP10.98, worth GBP4.4 million, on Wednesday. Now interested in 7.5 million shares, a 6.2% stake.

----------

Knights Group Holdings PLC - Staffordshire, England-based legal and professional services - Mark Beech, director of client services, sells 250,000 shares at GBP3.95, worth GBP987,500, on July 29.

----------

Volex PLC - Basingstoke, England-based connectivity and power products maker - Sharon Molloy, wife of Chief Operating Officer John Molloy, buys 98,561 shares at 137p, worth GBP135,029, on Wednesday. COO Molloy now interested in 1.3 million shares, a 0.8% stake.

----------

Senior PLC - Hertfordshire-based engineering firm for aerospace, defence, land vehicle and power & energy markets - Chair Ian King buys 207,000 shares at 48.27p, worth GBP99,919, on Tuesday. Now has 414,297 shares. Chief Executive David Squires buys 50,000 shares at 49.19p, worth GBP24,595, also on Tuesday. Now has 394,377 shares.

----------

NWF Group PLC - Cheshire-based distributor of fuel, feed and food - Julie Andrew, an associate of Company Secretary Rob Andrew, sells 10,000 shares at 209.1p, worth GBP20,910, on Tuesday. Rob Andrew now interested in 127,667 shares.

----------

Mereo Biopharma Group PLC - London-based clinical-stage biopharmaceutical firm - Chief Executive Officer Denise Scots-Knight buys 10,563 American Depositary Shares at USD2.85 per ADS, worth USD30,105, on July 31. Each ADS listed on Nasdaq equals five Mereo shares.

----------

Crest Nicholson Holdings PLC - Chertsey, Surrey-based housebuilder - Sally Nicholson, associate of COO Tom Nicholson, buys 11,000 shares at GBP1.86, worth GBP20,466, on Tuesday.

----------

Power Metal Resources PLC - exploring for gold in North America and Australia and for base metals in Africa - CEO Paul Johnson buys 1.4 million shares, directly and via Value Generation Ltd, at average 1.13p, worth GBP15,775, on Wednesday. Now holds 55.0 million shares, a 7.1% stake.

----------

Energean PLC - gas exploration and production in Mediterranean - Vassilis Tsetoglou, health & safety director, sells 2,000 shares at GBP5.80, worth GBP11,590, on Monday.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
21 Jan 2019 12:58

Scancell Appoints New Head Of Research And Manufacturing Divisions

LONDON (Alliance News) - Scancell Holdings PLC on Monday said it appointed two new executives as head of research and head of manufacturing.Samantha Paston joined Scancell as head of in She

Read more
5 Dec 2018 14:33

Mereo BioPharma To Acquire US Oncology Firm In All Stock Deal

LONDON (Alliance News) - Mereo BioPharma Group PLC on Wednesday said it will buy US oncology-focused clinical stage biopharmaceutical business OncoMed Pharmaceuticals Inc via a all-stock deal at a

Read more
5 Nov 2018 12:26

Mereo BioPharma Doses First Patient In Phase Two MPH-966 Study

LONDON (Alliance News) - Rare disease pharmaceutical company Mereo Biopharma Group PLC said on Monday it has has dosed its first patient in its Phase 2 clinical study of MPH-966, which is for the

Read more
15 Oct 2018 11:20

Mereo Completes Patient Enrolment In Brittle Bone Disease Drug Trial

LONDON (Alliance News) - Mereo Biopharma Group PLC on Monday said it has completed patient enrolment in its phase 2b clinical study of its drug BPS-804, or Setrusumab, which is being conducted in

Read more
1 Oct 2018 13:15

Mereo BioPharma Completes Positive Revision Of Credit Facility Terms (ALLISS)

LONDON (Alliance News) - Mereo BioPharma Group PLC said Monday that it completed a revision of the terms of its credit facility with Silicon Valley Bank and Kreos Capital.The revised terms

Read more
8 Aug 2018 12:53

Mereo BioPharma Considering Fundraise As Interim Loss Narrows

LONDON (Alliance News) - Mereo BioPharma Group PLC said Wednesday it continues to make progress on "all fronts" after narrowing its interim loss.For the six months to June 30, the

Read more
14 Jun 2018 14:40

UK Shareholder Meetings Calendar - Next 7 Days

Friday 15 JuneJD Sports Fashion (re acquisition of The Finish Line)MP Evans GroupBaker Steel 18 (re 19

Read more
29 May 2018 12:31

Mereo BioPharma Looks To Broaden Shareholder Base (ALLISS)

LONDON (Alliance News) - Mereo BioPharma Group PLC said Tuesday it placed 50,076 shares at 300 pence each.Following admission to trading of the new shares, which is expected to occur on 1,

Read more
26 Apr 2018 13:36

Mereo BioPharma Halts Listing On Nasdaq Due To Market Conditions (ALLIPO)

LONDON (Alliance News) - Mereo BioPharma Group PLC said on Thursday it has decided to postpone its proposed listing of American depository shares on the Nasdaq Global Market.Mereo said the

Read more
19 Mar 2018 13:14

Mereo BioPharma Hails Positive BGS-649 Phase II Clinical Trial Data

LONDON (Alliance News) - Mereo BioPharma Group PLC said Monday it had received positive top-line data for its phase II clinical trial for hypogonadotropic hypogonadism in said

Read more
12 Jan 2017 09:04

Diurnal Hires Outgoing Mereo BioPharma Finance Chief Bungay

Read more
16 Sep 2016 10:15

Mereo Biopharma Progresses Drug Candidates In Maiden Interim Period

Read more
11 Jul 2016 15:07

UK Shareholder Meetings Calendar - Next 7 Days

Read more
30 Jun 2016 08:07

Mereo Biopharma Gets European Approval For Bone Disorder Treatment

Read more
9 Jun 2016 08:36

Mereo Biopharma Shares Up 22% As It Starts Trading On AIM (ALLIPO)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.